<DOC>
	<DOCNO>NCT02339779</DOCNO>
	<brief_summary>This multicentre randomize control trial aim evaluate new breast reconstruction technique- autologous fat transfer ( AFT ) . Female patient breast cancer schedule receive mastectomy ( undergone mastectomy past ) randomize undergo breast reconstruction either AFT ( intervention group ) reconstruction implant ( control group ) . AFT evaluate term quality life , aesthetic result , complication , oncological safety cost-effectiveness .</brief_summary>
	<brief_title>Breast Reconstruction With External Pre-expansion Autologous Fat Transfer Versus Standard Therapy</brief_title>
	<detailed_description />
	<criteria>Female gender Age 18 year old History candidate mastectomy procedure near future Patients ' choice undergo breast reconstruction Wanting participate study Patient able wear BRAVA device Active smoker history smoke 3 month prior surgery Current substance abuse History lidocaine allergy History silicone allergy 6 week less chemotherapy History radiation therapy breast region Oncological treatment include radiotherapy mastectomy Kidney disease Steroid dependent asthma ( daily weekly ) disease Immunesuppressed compromised disease Uncontrolled diabetes BMI &gt; 30 Large breast size ( i.e . large cup C ) , unless patient prefers reduction contralateral side towards Cup C Extracapsular silicone leak encapsulate implant previous breast reconstruction The treat plastic surgeon strong doubt patient 's treatment compliance Claustrophobia MRIscan</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>fat graft</keyword>
	<keyword>fat injection</keyword>
	<keyword>lipoaspirate</keyword>
	<keyword>fat transfer</keyword>
	<keyword>lipofilling</keyword>
	<keyword>liposculpturing</keyword>
	<keyword>lipoinjection</keyword>
	<keyword>lipotransfer</keyword>
	<keyword>breast reconstruction</keyword>
</DOC>